Suppr超能文献

无细胞百日咳疫苗接种后发热性惊厥的口服地西泮治疗

Oral Diazepam in Febrile Seizures Following Acellular Pertussis Vaccination.

作者信息

Ghazavi Mohammadreza, Nasiri Jafar, Yaghini Omid, Soltani Rose

机构信息

Department of Pediatric Neurology and Child Growth and Development Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

Department of Pediatrics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

出版信息

Adv Biomed Res. 2019 Apr 26;8:29. doi: 10.4103/abr.abr_96_18. eCollection 2019.

Abstract

BACKGROUND

Febrile seizure is the most common type of seizures among children, which is a terrible and frightening experience for parents who are concerned about its recurrence. The aim of this study was to evaluate the effect of diazepam on preventing the recurrence of febrile seizure following acellular pertussis vaccination.

MATERIALS AND METHODS

In this clinical trial, 121 children with a history of febrile seizure that required the pertussis vaccination were enrolled and divided into two groups; the first group was treated with oral diazepam for 48 h after vaccine injection and the control group received antipyretics only if fever occurred after the vaccination and used rectal diazepam for controlling seizure if a seizure occurred. The incidence of fever and seizure after the injection of the vaccine and incidence of febrile seizure were compared.

RESULTS

Nearly, 85.7% in the oral diazepam group and 87.9% in the rectal diazepam group had fever after receiving the pertussis vaccine, but the incidence of fever was not significantly different between the groups. Seven children (12.06%) in the rectal diazepam group had a seizure after pertussis vaccination, and none of the children in the oral diazepam group had a seizure after receiving the vaccine at 18 months of age. This difference was significant.

CONCLUSION

Prophylaxis with diazepam administration in children with a history of febrile seizure can prevent recurrence of febrile seizure after pertussis vaccination.

摘要

背景

热性惊厥是儿童最常见的惊厥类型,对于担心其复发的父母来说,这是一段可怕且令人恐惧的经历。本研究的目的是评估地西泮对预防无细胞百日咳疫苗接种后热性惊厥复发的效果。

材料与方法

在这项临床试验中,纳入了121名有热性惊厥病史且需要接种百日咳疫苗的儿童,并将其分为两组;第一组在疫苗注射后口服地西泮48小时,对照组仅在接种疫苗后发热时使用退烧药,若发生惊厥则使用直肠用地西泮控制惊厥。比较疫苗注射后发热和惊厥的发生率以及热性惊厥的发生率。

结果

口服地西泮组近85.7%的儿童和直肠用地西泮组87.9%的儿童在接种百日咳疫苗后出现发热,但两组间发热发生率无显著差异。直肠用地西泮组有7名儿童(12.06%)在接种百日咳疫苗后发生惊厥,口服地西泮组在18个月龄接种疫苗后无儿童发生惊厥。这一差异具有统计学意义。

结论

对有热性惊厥病史的儿童预防性使用地西泮可预防百日咳疫苗接种后热性惊厥的复发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3bf/6507365/69a40344aa76/ABR-8-29-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验